Retsch reveals six innovations

Published: 24-Mar-2006
Manufacturing

Retsch and Retsch Technology are presenting six product innovations:

Retsch and Retsch Technology are presenting six product innovations:

  • The optical particle measurement system CAMSIZER for precise and efficient particle analysis with increased resolution in the micron range
  • The Planetary Ball Mill PM 400 with stronger performance and 1-button operation
  • The Mortar Grinder RM 200, the high-tech successor of the classic Retsch Mill
  • The Vibratory Disc Mill RS 200 that guarantees reproducible results with optimised grinding performance
  • The hydraulic Pellet Press PP 200 with a pressure of 40 tons
  • And the new Rapid Dryer TG 200 that dries the sample material without localised overheating and provides a loose, thoroughly mixed product.
Proven components of other mills, such as the 1-button operation with graphic display, have now been integrated in the PM 400 and RS 200. In addition to an improved performance, the instruments offer new features such as digital controls for parameter settings and the possibility to store up to 10 programs.

Hall 5.1, Stand D32-E34

  • Companies:
  • Retsch GmbH
See more

You may also like

Manufacturing

Lab Innovations welcomes more exhibitors and launches

Read more
Only event in the UK dedicated to laboratory equipment, technology and services

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
  3. Memel Biotech and Therabest collaborate to develop exosome-based cell therapies The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
  4. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
  5. How a circular economy can benefit pharma manufacturers Implementing a circular economy can be beneficial for the planet and your business, if you play your cards right

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Lab Innovations welcomes more exhibitors and launches

Only event in the UK dedicated to laboratory equipment, technology and services
Manufacturing

For easy transition from glass to plastic accessories - BOLA components with GL threads

The GL thread is the most common thread on lab equipment made of glass. Available from Labtex in the UK, BOLA offers a modular construction system with many different components with GL threads
Distribution

ChargePoint invest in a single-use manufacturing facility to expand product line

The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Manufacturing

Optimising RNA production for faster and cheaper pharmaceutical manufacturing

RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the avoidance of scaling issues
Manufacturing

Memel Biotech and Therabest collaborate to develop exosome-based cell therapies

The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Manufacturing

INEOS Nitriles launches INVIREO - the first bio-based acetonitrile

The company has released INVIERO, an acetonitrile capable of significantly reducing the carbon footprint of manufacturing processes
Manufacturing

Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities

Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Subscribe now